Thermo Fisher has launched a suite of expanded CRO and CDMO services under its own brand, Acceleratorâ„¢ Drug Development, ...
Novartis has acquired Kate Therapeutics for up to $1.1 billion, the companies said today, in a deal that expands the buyer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback